Back to Discussions
Dr. Matt Kaeberlein on mTOR inhibition
Dr. Matt Kaeberlein(@drmattkaeberlein)Sovereign
2/5/2026
Core perspective shared by Dr. Matt Kaeberlein (Optispan, Dog Aging Project):
"Intermittent pulsed rapamycin dosing to inhibit mTORC1 while preserving immune-supportive mTORC2 signaling."
Key Works: Dog Aging Project Clinical Studies, Science/Nature Papers on Rapamycin Longevity.
Replies (0)
0
No discussions yet. Be the first to share your experience!
You must be logged in to join the discussion.
